Association between immune-related adverse events and prognosis after immune checkpoint inhibitor in hepatocellular carcinoma: A meta-analysis and systematic review.

被引：0
|
作者：
Hwang, Soo Young
Rezaee-Zavareh, Mohammad Saeid
Attia, Abdelrahman M.
Kaymen, Emily
Tran, Nguyen H.
Abou-Alfa, Ghassan K.
Singal, Amit
Yang, Ju Dong
机构：
[1] Univ Maryland, Midtown Campus, Baltimore, MD USA
[2] Middle East Liver Dis MELD Ctr, Tehran, Iran
[3] Cedars Sinai Med Ctr, Karsh Div Gastroenterol & Hepatol, Comprehens Transplant Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA USA
[4] Cedars Sinai Med Ctr, Dept Oncol, Los Angeles, CA USA
[5] Mayo Clin Rochester, Dept Oncol, Rochester, MN USA
[6] Mem Sloan Kettering Canc Ctr, New York, NY USA
[7] Univ Texas SouthWestern Med Ctr, Dept Internal Med, Dallas, TX USA
[8] Cedars Sinai Med Ctr, Karsh Div Gastroenterol & Hepatol, Los Angeles, CA USA
[9] Cedars Sinai Med Ctr, Comprehens Transplant Ctr, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.4_suppl.566
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
566
引用
收藏
页码：566 / 566
页数：1
相关论文
共 50 条
  • [41] Are checkpoint inhibitor immune-related adverse events a prognosis factor in urothelial cancer?
    Falcao, Gil
    Carneiro, Cabrita
    Bernardino, Rui
    Guimaraes, Thiago
    Medeiros, Mariana
    Andrade, Vanessa
    Guerra, Joao
    Gil, Miguel
    Pinheiro, Luis Campos
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 : 24 - 24
  • [42] Not all immune-checkpoint inhibitors are created equal: Meta-analysis and systematic review of immune-related adverse events in cancer trials
    El Osta, B.
    Hu, F.
    Sadek, R.
    Chintalapally, R.
    Tang, S. -C.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 119 : 1 - 12
  • [43] The occurrence of immune-related adverse events indicates better efficacy of immune checkpoint blockade in solid tumors: A systematic review and meta-analysis
    Yang, Xu
    Wang, Dongxu
    Lin, Jianzhen
    Xiong, Jianping
    Long, Junyu
    Bai, Yi
    Bian, Jin
    Huang, Hanchun
    Yang, Xiaobo
    Mao, Yilei
    Sang, Xinting
    Zhao, Haitao
    CANCER RESEARCH, 2019, 79 (13)
  • [44] Management and Outcomes of Hematological Immune-related Adverse Events: Systematic Review and Meta-analysis
    Wilson, Nathaniel R.
    Lockhart, Jonathan R.
    Garcia-Perdomo, Herney A.
    Oo, Thein H.
    Rojas-Hernandez, Cristhiam M.
    JOURNAL OF IMMUNOTHERAPY, 2022, 45 (01) : 13 - 24
  • [45] Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitor Therapy
    Ho, Adrienne K.
    Ho, Anthony M-H
    Cooksley, Tim
    Nguyen, Giang
    Erb, Jason
    Mizubuti, Glenio B.
    ANESTHESIA AND ANALGESIA, 2021, 132 (02): : 374 - 383
  • [46] Association between immune-related adverse events and the prognosis of patients with gastric cancer treated with nivolumab: a meta-analysis
    Zhang, Ya-Jun
    Tian, Qian-Yu
    Wang, Cai-E.
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [47] Safety of immune checkpoint inhibitor rechallenge after severe immune-related adverse events: a retrospective analysis
    Eldani, Celine
    Kostine, Marie
    Faure, Maxime
    Lazaro, Estibaliz
    Rigothier, Claire
    Hiriart, Jean Baptiste
    Teulieres, Berenice
    Poullenot, Florian
    Haissaguerre, Magalie
    Zysman, Maeva
    Veillon, Remi
    Vergnenegre, Charlotte
    Issa, Nahema
    Domblides, Charlotte
    Mary-Prey, Sorilla
    Beylot-Barry, Marie
    Pham-Ledard, Anne
    Dutriaux, Caroline
    Sole, Guilhem
    Duval, Fanny
    Gerard, Emilie
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [48] Immune-related adverse events associated with first-line immune checkpoint inhibitors for metastatic renal cell carcinoma: A systematic review and network meta-analysis
    Wang, Shan
    Lv, Hongwei
    Yu, Jing
    Chen, Miao
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 131
  • [49] The incidence of immune-related adverse events (irAEs) and their association with clinical outcomes in advanced renal cell carcinoma and urothelial carcinoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis
    Zhang, Yaowen
    Chen, Junru
    Liu, Haoyang
    Dai, Jindong
    Zhao, Junjie
    Zhu, Sha
    Zhang, Xingming
    Liang, Jiayu
    Hu, Xu
    Zhao, Jinge
    Liu, Zhenhua
    Shen, Pengfei
    Sun, Guangxi
    Zeng, Hao
    CANCER TREATMENT REVIEWS, 2024, 129
  • [50] Safety and Efficacy of the Rechallenge of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer: A Systemic Review and Meta-Analysis
    Zhao, Qing
    Zhang, Jianwei
    Xu, Lingyi
    Yang, Huaxia
    Liang, Naixin
    Zhang, Li
    Zhang, Fengchun
    Zhang, Xuan
    FRONTIERS IN IMMUNOLOGY, 2021, 12
12345